What are Oral Antiviral Treatments?

The Food and Drug Administration (FDA) issued an emergency use authorization for molnupirvar by Merck and an emergency use authorization for Paxlovid™ by Pfizer as oral antiviral treatments of COVID-19. Early studies indicate these treatment options may reduce severe outcomes from COVID-19 including hospitalization or death. These treatments are recommended for individuals who are at high risk for progression to severe COVID-19 or have underlying medical conditions.

Where Are These Treatment Options Available?

The Tennessee Department of Health coordinated a distribution plan of molnupiravir and Paxlovid™ with Walmart pharmacies across the state. This medication is free, and Tennesseans can visit www.walmart.com/covidmedication to find a participating Walmart pharmacy near them.
These therapies require a prescription by a licensed and authorized provider. You should coordinate with your health care provider prior to contacting a location to receive these therapies.
For more information on Test-to-Treat locations please visit https://covid-19-test-to-treat-locator-dhhs.hub.arcgis.com/